Electrophysiological characterization of the polyspecific organic cation transporter plasma membrane monoamine transporter

Drug Metabolism and Disposition

Volumn 40, Issue 6, 2012, Pages 1138-1143

  Itagaki, Shiro ^a,c   Ganapathy, Vadivel ^a   Ho, Horace T B ^b   Zhou, Mingyan ^b,d   Babu, Ellappan ^a   Wang, Joanne ^b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c HIROSAKI UNIVERSITY HOSPITAL   (Japan)

^d HOFFMANN LA ROCHE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE; NICOTINE; ORGANIC CATION TRANSPORTER; PLASMA MEMBRANE MONOAMINE TRANSPORTER; SODIUM ION; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CATION TRANSPORT; CELL MEMBRANE POTENTIAL; CONTROLLED STUDY; FEMALE; MEMBRANE ELECTROPHYSIOLOGY; MICHAELIS MENTEN KINETICS; MICROELECTRODE; NONHUMAN; OOCYTE; PH; PRIORITY JOURNAL; SLOW INWARD CURRENT; TRANSPORT KINETICS; VOLTAGE CLAMP; XENOPUS LAEVIS;

ANIMALS; CELL MEMBRANE; ELECTROPHYSIOLOGICAL PHENOMENA; EQUILIBRATIVE NUCLEOSIDE TRANSPORT PROTEINS; FEMALE; HUMANS; MEMBRANE POTENTIALS; ORGANIC CATION TRANSPORT PROTEINS; XENOPUS LAEVIS; XENOPUS PROTEINS;

XENOPUS LAEVIS;

EID: 84861978185     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.111.042432     Document Type: Article

References (33)

1. Budiman T, Bamberg E, Koepsell H, and Nagel G (2000) Mechanism of electrogenic cation transport by the cloned organic cation transporter 2 from rat. J Biol Chem 275:29413-29420. (Pubitemid 32043815)
2. Busch AE, Quester S, Ulzheimer JC, Waldegger S, Gorboulev V, Arndt P, Lang F, and Koepsell H (1996) Electrogenic properties and substrate specificity of the polyspecific rat cation transporter rOCT1. J Biol Chem 271:32599-32604. (Pubitemid 27008679)
3. Dahlin A, Royall J, Hohmann JG, and Wang J (2009) Expression profiling of the solute carrier gene family in the mouse brain. J Pharmacol Exp Ther 329:558-570.
4. Dahlin A, Xia L, Kong W, Hevner R, and Wang J (2007) Expression and immunolocalization of the plasma membrane monoamine transporter in the brain. Neuroscience 146:1193-1211. (Pubitemid 46694120)
5. Dascal N (2001) Voltage clamp recordings from Xenopus oocytes. Curr Protoc Neurosci Chapter 6: Unit 6.12.
6. Dascal N, Landau EM, and Lass Y (1984) Xenopus oocyte resting potential, muscarinic responses and the role of calcium and guanosine 3′,5′- cyclic monophosphate. J Physiol 352:551-574. (Pubitemid 14059639)
7. Dresser MJ, Gray AT, and Giacomini KM (2000) Kinetic and selectivity differences between rodent, rabbit, and human organic cation transporters (OCT1). J Pharmacol Exp Ther 292: 1146-1152. (Pubitemid 30136612)
8. Duan H and Wang J (2010) Selective transport of monoamine neurotransmitters by human plasma membrane monoamine transporter and organic cation transporter 3. J Pharmacol Exp Ther 335:743-753.
9. Engel K and Wang J (2005) Interaction of organic cations with a newly identified plasma membrane monoamine transporter. Mol Pharmacol 68:1397-1407. (Pubitemid 41539995)
10. Engel K, Zhou M, and Wang J (2004) Identification and characterization of a novel monoamine transporter in the human brain. J Biol Chem 279:50042-50049. (Pubitemid 39577815)
11. Fei YJ, Prasad PD, Leibach FH, and Ganapathy V (1995) The amino acid transport system y+L induced in Xenopus laevis oocytes by human choriocarcinoma cell (JAR) mRNA is functionally related to the heavy chain of the 4F2 cell surface antigen. Biochemistry 34:8744-8751.
12. Fujita T, Urban TJ, Leabman MK, Fujita K, and Giacomini KM (2006) Transport of drugs in the kidney by the human organic cation transporter, OCT2 and its genetic variants. J Pharm Sci 95:25-36.
13. Gorboulev V, Ulzheimer JC, Akhoundova A, Ulzheimer-Teuber I, Karbach U, Quester S, Baumann C, Lang F, Busch AE, and Koepsell H (1997) Cloning and characterization of two human polyspecific organic cation transporters. DNA Cell Biol 16:871-881. (Pubitemid 27332696)
14. Gründemann D, Babin-Ebell J, Martel F, Ording N, Schmidt A, and Schömig E (1997) Primary structure and functional expression of the apical organic cation transporter from kidney epithelial LLC-PK1 cells. J Biol Chem 272:10408-10413.
15. Ho HT, Pan Y, Cui Z, Duan H, Swaan PW, and Wang J (2011) Molecular analysis and structure-activity relationship modeling of the substrate/inhibitor interaction site of plasma membrane monoamine transporter. J Pharmacol Exp Ther 339:376-385.
16. Kekuda R, Prasad PD, Wu X, Wang H, Fei YJ, Leibach FH, and Ganapathy V (1998) Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta. J Biol Chem 273:15971-15979. (Pubitemid 28311362)
17. Koepsell H and Endou H (2004) The SLC22 drug transporter family. Pflugers Arch 447:666-676. (Pubitemid 38241452)
18. Koepsell H, Schmitt BM, and Gorboulev V (2003) Organic cation transporters. Rev Physiol Biochem Pharmacol 150:36-90.
19. Kong W, Engel K, and Wang J (2004) Mammalian nucleoside transporters. Curr Drug Metab 5:63-84. (Pubitemid 38279408)
20. +/glucose cotransporter. Proc Natl Acad Sci USA 90:5767-5771.
21. +/ organic cation antiporter, kidney-specific multidrug and toxin extrusion 2. J Am Soc Nephrol 17:2127-2135.
22. Okuda M, Saito H, Urakami Y, Takano M, and Inui K (1996) cDNA cloning and functional expression of a novel rat kidney organic cation transporter, OCT2. Biochem Biophys Res Commun 224:500-507. (Pubitemid 26268216)
23. Okura T, Kato S, Takano Y, Sato T, Yamashita A, Morimoto R, Ohtsuki S, Terasaki T, and Deguchi Y (2011) Functional characterization of rat plasma membrane monoamine transporter in the blood-brain and blood-cerebrospinal fluid barriers. J Pharm Sci 100:3924-3938.
24. Otsuka M, Matsumoto T, Morimoto R, Arioka S, Omote H, and Moriyama Y (2005) A human transporter protein that mediates the final excretion step for toxic organic cations. Proc Natl Acad Sci USA 102:17923-17928. (Pubitemid 41798478)
25. Sweet DH and Pritchard JB (1999) rOCT2 is a basolateral potential-driven carrier, not an organic cation/proton exchanger. Am J Physiol 277:F890-F898. (Pubitemid 30046064)
26. +/organic cation antiporter MATE1. Pharm Res 23:1696-1701.
27. Urakami Y, Okuda M, Masuda S, Saito H, and Inui KI (1998) Functional characteristics and membrane localization of rat multispecific organic cation transporters, OCT1 and OCT2, mediating tubular secretion of cationic drugs. J Pharmacol Exp Ther 287:800-805. (Pubitemid 29133685)
28. Wright SH and Dantzler WH (2004) Molecular and cellular physiology of renal organic cation and anion transport. Physiol Rev 84:987-1049. (Pubitemid 38823772)
29. Wu X, Kekuda R, Huang W, Fei YJ, Leibach FH, Chen J, Conway SJ, and Ganapathy V (1998) Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain. J Biol Chem 273:32776-32786. (Pubitemid 28557664)
30. Xia L, Engel K, Zhou M, and Wang J (2007) Membrane localization and pH-dependent transport of a newly cloned organic cation transporter (PMAT) in kidney cells. Am J Physiol Renal Physiol 292:F682-F690. (Pubitemid 46220537)
31. Xia L, Zhou M, Kalhorn TF, Ho HT, and Wang J (2009) Podocyte-specific expression of organic cation transporter PMAT: implication in puromycin aminonucleoside nephrotoxicity. Am J Physiol Renal Physiol 296:F1307-F1313.
32. Zhou M, Engel K, and Wang J (2007a) Evidence for significant contribution of a newly identified monoamine transporter (PMAT) to serotonin uptake in the human brain. Biochem Pharmacol 73:147-154. (Pubitemid 44853932)
33. Zhou M, Xia L, and Wang J (2007b) Metformin transport by a newly cloned proton-stimulated organic cation transporter (plasma membrane monoamine transporter) expressed in human intestine. Drug Metab Dispos 35:1956-1962. (Pubitemid 47481592)